Diagonal Bio AB

OSTO:DIABIO (Sweden)   Ordinary Shares
kr 0.03 (+3%) May 22
At Loss
P/B:
0.09
Market Cap:
kr 12.38M ($ 1.16M)
Enterprise V:
kr 9.41M ($ 878.00K)
Volume:
11.59M
Avg Vol (2M):
4.84M
Also Trade In:
Volume:
11.59M
At Loss
Avg Vol (2M):
4.84M

Business Description

Description
Diagonal Bio AB is developing a diagnostic platform for ultra-rapid, parallel, accurate and cost-efficient detection of any kind of pathogen - Panviral.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.75
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -3.6
Distress
Grey
Safe
Beneish M-Score 6.01
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year Book Growth Rate -2.5

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 24.84
9-Day RSI 30
14-Day RSI 34.41
6-1 Month Momentum % -53.22
12-1 Month Momentum % -63.37

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.65
Quick Ratio 0.51
Cash Ratio 0.41
Days Sales Outstanding 365

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -37

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 9139.13
Operating Margin % -34204.35
Net Margin % -34717.39
FCF Margin % -11186.96
ROE % -31.6
ROA % -26.27
ROIC % -30.64
ROC (Joel Greenblatt) % -35359.09
ROCE % -30.79

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 30.9
PB Ratio 0.09
EV-to-EBIT -1.21
EV-to-EBITDA -1.21
EV-to-Revenue 409.05
EV-to-FCF -3.52
Earnings Yield (Greenblatt) % -82.9
FCF Yield % -20.79

Financials (Next Earnings Date:2024-05-31)

OSTO:DIABIO's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Diagonal Bio AB Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil kr) 0.023
EPS (TTM) (kr) -0.134
Beta 0
Volatility % 193.09
14-Day RSI 34.41
14-Day ATR (kr) 0.014016
20-Day SMA (kr) 0.06139
12-1 Month Momentum % -63.37
52-Week Range (kr) 0.028 - 0.498753
Shares Outstanding (Mil) 400.64

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Diagonal Bio AB Filings

Filing Date Document Date Form
No Filing Data

Diagonal Bio AB Stock Events

Financials Calendars
Event Date Price(kr)
No Event Data

Diagonal Bio AB Frequently Asked Questions

What is Diagonal Bio AB(OSTO:DIABIO)'s stock price today?
The current price of OSTO:DIABIO is kr0.03. The 52 week high of OSTO:DIABIO is kr0.50 and 52 week low is kr0.03.
When is next earnings date of Diagonal Bio AB(OSTO:DIABIO)?
The next earnings date of Diagonal Bio AB(OSTO:DIABIO) is 2024-05-31.
Does Diagonal Bio AB(OSTO:DIABIO) pay dividends? If so, how much?
Diagonal Bio AB(OSTO:DIABIO) does not pay dividend.

Press Release

Subject Date
No Press Release